InsamoInsamo Cyclic Peptide Drug Discovery Platform

The platform integrates machine learning-driven molecular design, ultra high-throughput molecular biology, and parallel synthetic chemistry to generate preclinical candidates against challenging intracellular and undruggable targets. It iterates across trillions of proprietary experimental data points within a drug-like chemical space, aiming to replace injected or infused biologics with oral cyclic-peptide formulations.

Insamo's approach automates the design-build-test cycle for macrocyclic peptides, producing molecules that retain high binding affinity while penetrating cell membranes, enabling the development of oral therapeutics for targets historically inaccessible to large-molecule drugs.